New Guidelines for the Treatment of Drug-Susceptible Tuberculosis from the American Thoracic Society, Centers for Disease Control and Prevention, and the Infectious Diseases Society of America. Now Comes the Hard Part-Reference-Cited by-同舟云学术

New Guidelines for the Treatment of Drug-Susceptible Tuberculosis from the American Thoracic Society, Centers for Disease Control and Prevention, and the Infectious Diseases Society of America. Now Comes the Hard Part

Published:2016-10 Issue:7 Volume:194 Page:791-793
ISSN:1073-449X
Container-title:American Journal of Respiratory and Critical Care Medicine
language:en
Short-container-title:Am J Respir Crit Care Med

Author:

Metersky Mark L.^ORCID,Schluger Neil W.^ORCID

Publisher

American Thoracic Society

Subject

Critical Care and Intensive Care Medicine,Pulmonary and Respiratory Medicine

Reference14 articles.

1. American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America

2. Leveling of Tuberculosis Incidence — United States, 2013–2015

3. Smith MSR, Struckhard L, McGinnis JM. Best care at lower cost: the path to continuously learning health care in America. Washington, DC: The National Academies Press; 2013.

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prevalence, Clinical Reasons and Associated Factors of Extended Treatment Duration for Drug Susceptible Tuberculosis – a Real-World Experience;2023-09-26

2. Incidence and assessment of demography-related risk factors associated with pulmonary tuberculosis in Saudi Arabia: A retrospective analysis;Pakistan Journal of Medical Sciences;2022-03-05

3. A Saudi Arabian Public Health Perspective of Tuberculosis;International Journal of Environmental Research and Public Health;2021-09-24

4. Frequency, Risk Factors, and Outcome of Active Tuberculosis following Allogeneic Hematopoietic Stem Cell Transplantation;Biology of Blood and Marrow Transplantation;2020-06

5. Long-term efficacy of 6-month therapy with isoniazid and rifampin compared with isoniazid, rifampin, and pyrazinamide treatment for pleural tuberculosis;European Journal of Clinical Microbiology & Infectious Diseases;2019-08-03